Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERDAFITINIB vs ERIBULIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERDAFITINIB vs ERIBULIN: Safety Overview

Metric ERDAFITINIB ERIBULIN
Total FAERS Reports 1,106 5,055
Deaths Reported 315 793
Death Rate 28.5% 15.7%
Hospitalizations 226 2,642
Average Patient Age 66.6 yrs 57.3 yrs
% Female Patients 37.9% 93.0%
FDA Approval Date Apr 12, 2019 Apr 5, 2024
Manufacturer Janssen Products LP Gland Pharma Limited
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription